Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Atypical respiratory pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Immunoenzymatic dot-blot test for the diagnosis of enteric fever caused by Salmonella typhi in an endemic area  Nora Cardona-Castro, Piedad Agudelo-Flórez 
R. Cantón  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus  P.-R. Hsueh, L.-M. Huang, P.-J.
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis  S. Chatzipanagiotou, J.N.
L. Gatta, C. Ricci, A. Tampieri, D. Vaira 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Sepsis and neutropenia induced by clozapine
Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients  Giampietro Nardi,
Uncommon opportunistic fungi: new nosocomial threats
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
G.R. Davies  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
Brucella detection in blood: comparison of the BacT/Alert standard aerobic bottle, BacT/Alert FAN aerobic bottle and BacT/Alert enhanced FAN aerobic bottle.
Community-acquired pneumonia: epidemiologic and clinical consideration
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Training in infectious diseases and tropical medicine in Britain
J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A
Fibronectin concentrations in catheter sepsis
Andrew M. Middleton, Maureen V. Chadwick, Harold Gaya 
Clinical infection services—the Leiden experience
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Statin use and clinical outcomes among pneumonia patients
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Overview of cefixime use in community-acquired infections
Brita Bruun, Henrik Westh, Jørgen Stenderup 
The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece  J. Papaparaskevas, J. Stefanou, A. Vatopoulos,
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Javier Aznar, Hassan Safi, Maria C. Conejo, José C. Palomares 
D.L. Monnet, T.L. Sørensen  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
Three years experience of real-time PCR for the diagnosis of Q fever
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Localized Mycobacterium avium complex infection in a patient on HAART
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María del Carmen Maroto  Clinical Microbiology and Infection  Volume 3, Issue 6, Pages 658-662 (December 1997) DOI: 10.1111/j.1469-0691.1997.tb00474.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Evolution of percentage low-avidity IgG in patients Nos 3, 4 and 12 (group I) and subject 5 (group IIa). Clinical Microbiology and Infection 1997 3, 658-662DOI: (10.1111/j.1469-0691.1997.tb00474.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.